| Pregnancy |
1 |
1 |
| Uterus |
0 |
0.72 |
| Vagina |
0 |
0.58 |
| Biologic Therapy |
0 |
0.3 |
| Oxytocin |
0 |
0.23 |
| Osteoarthritis |
0 |
0.18 |
| Cervical Ripening |
0 |
0.17 |
| Prostaglandin |
0 |
0.17 |
| Congenital Heart Disease |
0 |
0.14 |
| Healthcare and Medical Technology |
0 |
0.12 |
| Patient Safety |
0 |
0.12 |
| Fever |
0 |
0.1 |
| Pain Management |
0 |
0.09 |
| Cervix |
0 |
0.08 |
| Clinical Pharmacology |
0 |
0.08 |
| Plasma |
0 |
0.08 |
| Postpartum Hemorrhage |
0 |
0.08 |
| Calcium |
0 |
0.06 |
| Diarrhea |
0 |
0.06 |
| Erectile Dysfunction |
0 |
0.06 |
| Gastric Ulcer |
0 |
0.06 |
| Headache |
0 |
0.06 |
| Interleukin |
0 |
0.06 |
| Spontaneous Abortion |
0 |
0.06 |
| Abortion |
0 |
0.04 |
| Adverse Effects |
0 |
0.04 |
| Birth |
0 |
0.04 |
| Clinical Research |
0 |
0.04 |
| Electron Microscopy |
0 |
0.04 |
| Heart |
0 |
0.04 |
| Hemorrhage |
0 |
0.04 |
| Immunohistochemistry |
0 |
0.04 |
| Management of the Third Stage of Labor |
0 |
0.04 |
| Postpartum |
0 |
0.04 |
| Receptors |
0 |
0.04 |
| Self-Administration |
0 |
0.04 |
| Umbilical Cord |
0 |
0.03 |
| Abdomen |
0 |
0.02 |
| Artery |
0 |
0.02 |
| Biopsy |
0 |
0.02 |
| Cesarean Delivery |
0 |
0.02 |
| First Trimester Pregnancy |
0 |
0.02 |
| Food and Drug Administration (FDA) |
0 |
0.02 |
| Hypothalamus |
0 |
0.02 |
| Incision |
0 |
0.02 |
| Intravenous |
0 |
0.02 |
| Nausea |
0 |
0.02 |
| New Jersey |
0 |
0.02 |
| Newborn |
0 |
0.02 |
| Nonsteroidal Anti-Inflammatory Agents |
0 |
0.02 |
| Patent Ductus Arteriosus (PDA) |
0 |
0.02 |
| Tissue |
0 |
0.02 |
| Tumor |
0 |
0.02 |
| Umbilical |
0 |
0.02 |